POLYTHERAPIE POUR LE TRAITEMENT DU CANCER A L'AIDE D'UN POXVIRUS EXPRIMANT UN ANTIGENE TUMORAL ET D'UN ANTAGONISTE ET/OU AGONISTE D'UN INHIBITEUR DE POINT DE CONTROLE IMMUNITAIRE
The present disclosure encompasses therapies, compositions, and methods for treatment of a human cancer patient using a recombinant poxvirus encoding a tumor-associated antigen in combination with one or more agonists or antagonists of immune checkpoint inhibitors.